Unleashing the Power of Virtual Reality: McMaster University & Virtualware’s IMRSV@Mac VR Lab!
May 31, 2023 09:48 ET
|
Virtualware
HAMILTON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- The Faculty of Engineering at McMaster University, in partnership with the VR company Virtualware (EPA: MLVIR), officially announces the grand...
MediPharm Labs Enters Research Agreement with McMaster University to Develop Drugs Containing Cannabis Candidates
June 21, 2021 07:00 ET
|
MediPharm Labs Corp.
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation protocol and provide regulatory support for multiple...
Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip™ Product
February 04, 2020 07:15 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) (“RDT” or the “Corporation”) is pleased to announce the company has...
Rapid Dose Therapeutics and McMaster University Awarded NSERC Research and Development Grant to Develop Oral Dissolvable Film for Enhanced Drug Delivery
January 23, 2020 07:30 ET
|
Rapid Dose Therapeutics
BURLINGTON, Ontario, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce their newest research partnership program...
Qu Biologics Begins Research with McMaster University to Study New Crohn's Disease Research Model
December 03, 2013 10:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the...